Science 37 to Report Third Quarter 2021 Financial Results on November 15, 2021
November 01 2021 - 8:00AM
Science 37 Holdings, Inc. (Nasdaq: SNCE), the Operating System for
today’s more agile clinical trials, today announced it will report
third quarter 2021 financial results before the market opens on
Monday, November 15, 2021. Company management will host a
corresponding conference call at 5:00 a.m. Pacific Time / 8:00 a.m.
Eastern Time.
Investors interested in listening to the conference call may do
so by dialing (844) 467-7754 for domestic callers or (270) 215-9366
for international callers, followed by Conference ID: 3157111. A
live and archived webcast of the event will be available on the
Investor Relations section of the Science 37 website at
https://investors.science37.com/.
About Science 37
Science 37, Inc.’s mission is to enable universal access to
clinical research—making it easier for patients and providers to
participate from anywhere and helping to accelerate the development
of treatments that impact patient lives. As a pioneer of
decentralized clinical trials, the Science 37 Clinical Trial
Operating System (OS) supports today’s more agile clinical research
designs with its full stack, end-to-end technology platform and
specialized networks of patient communities, telemedicine
investigators, mobile nurses, remote coordinators and connected
devices. Configurable to enable any study type, the Science 37 OS
enables up to 15x faster enrollment, 28% better retention and 3x
more diverse patient population with industry-leading workflow
orchestration, evidence generation and data harmonization. For more
information, visit https://www.science37.com.
Contacts:
MEDIA INQUIRIES:Margie KoomanScience 37Phone:
(984) 377-3737Email: pr@science37.com
INVESTOR RELATIONS:Caroline PaulGilmartin
Groupinvestors@science37.com
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jul 2023 to Jul 2024